FDA Inspection 1194879 — Dottikon Exclusive Synthesis AG
The FDA completed an inspection of Dottikon Exclusive Synthesis AG on December 16, 2022 in Dottikon. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- December 16, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Dottikon (Switzerland)